Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis.
暂无分享,去创建一个
J. Stricker | A. Gardemann | H. Tillmanns | W. Haberbosch | F. Hehrlein | M. Philipp | N. Katz | J. Humme | J. Stricker | Q. D. Nguyen | Jörg Humme | H. Tillmanns | Werner Haberbosch | Andreas Gardemann | Quoc D Nguyen | Friedrich Wilhelm Hehrlein
[1] J. Stricker,et al. ACE I/D gene polymorphism: presence of the ACE D allele increases the risk of coronary artery disease in younger individuals. , 1998, Atherosclerosis.
[2] Y. Ko,et al. Angiotensinogen and angiotensin-I converting enzyme gene polymorphisms and the risk of coronary artery disease in Chinese , 1997, Human Genetics.
[3] T. Sørensen,et al. ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. , 1997, Circulation.
[4] W. Grzeszczak,et al. Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy , 1996 .
[5] N. Samani,et al. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. , 1996, Circulation.
[6] S. Jeffery,et al. Angiotensin-converting enzyme gene polymorphism. What to do about all the confusion. , 1996, Circulation.
[7] H. Parving,et al. Angiotensinogen Gene Polymorphisms in IDDM Patients With Diabetic Nephropathy , 1996, Diabetes.
[8] T. Arinami,et al. Absence of association of angiotensinogen gene T235 allele with increased risk of coronary heart disease in Japanese , 1995, The Lancet.
[9] T. Yee,et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease , 1995, The Lancet.
[10] R Kreutz,et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. , 1995, The New England journal of medicine.
[11] A. Evans,et al. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction , 1995, Journal of Hypertension.
[12] R. Hegele,et al. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. , 1994, Circulation.
[13] P Ducimetière,et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction , 1994, The Lancet.
[14] W. Maerz,et al. Rapid detection of the hypertension-associated Met235-->Thr allele of the human angiotensinogen gene. , 1993, Human molecular genetics.
[15] H. Sasamura,et al. Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacological implications. , 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[16] Steven C. Hunt,et al. Molecular basis of human hypertension: Role of angiotensinogen , 1992, Cell.
[17] Philippe Amouyel,et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.
[18] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[19] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[20] A. Chobanian,et al. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. , 1990, Hypertension.
[21] G. Åberg,et al. Effects of Captopril on Atherosclerosis in Cynomolgus Monkeys , 1990, Journal of cardiovascular pharmacology.
[22] R. Prewitt,et al. Captopril Reduces Aortic and Microvascular Growth in Hypertensive and Normotensive Rats , 1990, Hypertension.
[23] H. Baumgartner,et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. , 1989, Science.
[24] G. Gensini,et al. A more meaningful scoring system for determining the severity of coronary heart disease. , 1983, The American journal of cardiology.
[25] I. Borecki,et al. Associations between candidate loci angiotensin-converting enzyme and angiotensinogen with coronary heart disease and myocardial infarction: the NHLBI Family Heart Study. , 1997, Annals of epidemiology.